Radioimmunoassay Market Global Forecast to 2020 - The European Radioimmunoassay (RIA) Market Contributed the Largest Share, and was Valued at $121.5 Million in 2014

Nov 26, 2015, 01:30 ET from Research and Markets

DUBLIN, November 26, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/plc28h/radioimmunoassay) has announced the addition of the "Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), and Geography - Global Forecast to 2020" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The global radioimmunoassay market was dominated by Europe in 2014, followed by North America, Asia, and the Rest of the World (RoW). Europe is expected to continue to lead the market in the coming years, followed by North America. Over the years, there has been a significant growth in the utilization of the radioimmunoassay technique in Europe owing to the advancements in medical research, clinical trials, and pharmaceutical industries. Over the next five years, the growth in the Asian Radioimmunoassay (RIA) Market is expected to be centred in China, India, and Japan.

The global radioimmunoassay market was valued at $345.2 Million in 2014. The European radioimmunoassay (RIA) market contributed the largest share to the global market, and was valued at $121.5 Million in 2014. It is projected to grow at a CAGR of 3.9% during the forecast period from 2015 to 2020. North America was the second-largest market, and the market in this region is expected to be driven by the gradually increasing awareness, investments by government & non-government organizations, and establishment of research centres.

The report includes company profiles of major players, recent activities in the market, new product launches, mergers & acquisitions, collaborations and partnerships, and SWOT analysis. Some of the companies profiled in this report are DIAsource ImmunoAssays SA (Belgium), Beckman Coulter, Inc. (U.S.), IBL International (A Tecan Company) (Germany), PerkinElmer, Inc. (U.S.), DRG International, Inc. (U.S.), MP Biomedicals, LLC (U.S.), Cisbio (France), Euro Diagnostica AB (Sweden), DiaSorin S.p.A.. (Italy), EMD Millipore (U.S.), Izotop (Hungary), Berthold Technologies GmbH & Co. KG (Germany), and Stratec Biomedical AG (Germany), among others.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Market Overview

5 Radioimmunoassay (RIA) Market, By Type

6 Radioimmunoassay (RIA) Market, By End User

7 Radioimmunoassay (RIA) Market, By Application

8 Radioimmunoassay Market, By Geography

9 Competitive Landscape

10 Company Profiles

11 Appendix

For more information visit http://www.researchandmarkets.com/research/plc28h/radioimmunoassay


Media Contact:
Laura Wood ,
+353-1-481-1716,
press@researchandmarkets.net

SOURCE Research and Markets